These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19602592)

  • 21. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.
    Bracken AP; Dietrich N; Pasini D; Hansen KH; Helin K
    Genes Dev; 2006 May; 20(9):1123-36. PubMed ID: 16618801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a.
    Yap KL; Li S; Muñoz-Cabello AM; Raguz S; Zeng L; Mujtaba S; Gil J; Walsh MJ; Zhou MM
    Mol Cell; 2010 Jun; 38(5):662-74. PubMed ID: 20541999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes.
    Cai Y; Geutjes EJ; de Lint K; Roepman P; Bruurs L; Yu LR; Wang W; van Blijswijk J; Mohammad H; de Rink I; Bernards R; Baylin SB
    Oncogene; 2014 Apr; 33(17):2157-68. PubMed ID: 23708667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.
    Fang MZ; Wang Y; Ai N; Hou Z; Sun Y; Lu H; Welsh W; Yang CS
    Cancer Res; 2003 Nov; 63(22):7563-70. PubMed ID: 14633667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RYBP and Cbx7 define specific biological functions of polycomb complexes in mouse embryonic stem cells.
    Morey L; Aloia L; Cozzuto L; Benitah SA; Di Croce L
    Cell Rep; 2013 Jan; 3(1):60-9. PubMed ID: 23273917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10-ERK signaling.
    Huang Z; Yan Y; Zhu Z; Liu J; He X; Dalangood S; Li M; Tan M; Cai J; Tang P; Huang R; Shen B; Yan J
    Cell Death Dis; 2021 May; 12(6):537. PubMed ID: 34035231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procaine is a specific DNA methylation inhibitor with anti-tumor effect for human gastric cancer.
    Li YC; Wang Y; Li DD; Zhang Y; Zhao TC; Li CF
    J Cell Biochem; 2018 Feb; 119(2):2440-2449. PubMed ID: 28926119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA-intercalators causing rapid re-expression of methylated and silenced genes in cancer cells.
    Hossain MZ; Healey MA; Lee C; Poh W; Yerram SR; Patel K; Azad NS; Herman JG; Kern SE
    Oncotarget; 2013 Feb; 4(2):298-309. PubMed ID: 23593653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficiency of the Polycomb Protein RYBP and TET Methylcytosine Oxidases Promotes Extensive CpG Island Hypermethylation and Malignant Transformation.
    Cui W; Huang Z; Jin SG; Johnson J; Lau KH; Hostetter G; Pfeifer GP
    Cancer Res; 2023 Aug; 83(15):2480-2495. PubMed ID: 37272752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNMTs and SETDB1 function as co-repressors in MAX-mediated repression of germ cell-related genes in mouse embryonic stem cells.
    Tatsumi D; Hayashi Y; Endo M; Kobayashi H; Yoshioka T; Kiso K; Kanno S; Nakai Y; Maeda I; Mochizuki K; Tachibana M; Koseki H; Okuda A; Yasui A; Kono T; Matsui Y
    PLoS One; 2018; 13(11):e0205969. PubMed ID: 30403691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer.
    Teneng I; Tellez CS; Picchi MA; Klinge DM; Yingling CM; Snider AM; Liu Y; Belinsky SA
    Oncogene; 2015 Jan; 34(5):621-30. PubMed ID: 24469050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA methylation associated with polycomb repression in retinoic acid receptor β silencing.
    Moison C; Senamaud-Beaufort C; Fourrière L; Champion C; Ceccaldi A; Lacomme S; Daunay A; Tost J; Arimondo PB; Guieysse-Peugeot AL
    FASEB J; 2013 Apr; 27(4):1468-78. PubMed ID: 23299856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing.
    Ohm JE; McGarvey KM; Yu X; Cheng L; Schuebel KE; Cope L; Mohammad HP; Chen W; Daniel VC; Yu W; Berman DM; Jenuwein T; Pruitt K; Sharkis SJ; Watkins DN; Herman JG; Baylin SB
    Nat Genet; 2007 Feb; 39(2):237-42. PubMed ID: 17211412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer.
    Singh V; Sharma P; Capalash N
    Curr Cancer Drug Targets; 2013 May; 13(4):379-99. PubMed ID: 23517596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island.
    O'Hagan HM; Mohammad HP; Baylin SB
    PLoS Genet; 2008 Aug; 4(8):e1000155. PubMed ID: 18704159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer.
    Shiah SG; Hsiao JR; Chang HJ; Hsu YM; Wu GH; Peng HY; Chou ST; Kuo CC; Chang JY
    J Biomed Sci; 2020 Apr; 27(1):46. PubMed ID: 32238162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter.
    Wu LP; Wang X; Li L; Zhao Y; Lu S; Yu Y; Zhou W; Liu X; Yang J; Zheng Z; Zhang H; Feng J; Yang Y; Wang H; Zhu WG
    Mol Cell Biol; 2008 May; 28(10):3219-35. PubMed ID: 18332107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the polycomb repressive complex 2 in acute promyelocytic leukemia.
    Villa R; Pasini D; Gutierrez A; Morey L; Occhionorelli M; Viré E; Nomdedeu JF; Jenuwein T; Pelicci PG; Minucci S; Fuks F; Helin K; Di Croce L
    Cancer Cell; 2007 Jun; 11(6):513-25. PubMed ID: 17560333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands.
    O'Hagan HM; Wang W; Sen S; Destefano Shields C; Lee SS; Zhang YW; Clements EG; Cai Y; Van Neste L; Easwaran H; Casero RA; Sears CL; Baylin SB
    Cancer Cell; 2011 Nov; 20(5):606-19. PubMed ID: 22094255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression.
    Pickl JM; Tichy D; Kuryshev VY; Tolstov Y; Falkenstein M; Schüler J; Reidenbach D; Hotz-Wagenblatt A; Kristiansen G; Roth W; Hadaschik B; Hohenfellner M; Duensing S; Heckmann D; Sültmann H
    Oncotarget; 2016 Sep; 7(37):59589-59603. PubMed ID: 27449098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.